China Literature's Short-Form Drama Mid-Year Report: Hit Rate Three Times Industry Average, Female-Oriented Original IP Profits Exceed $5 Million

Deep News
07/22

China Literature has released its performance report for the first half of 2026 in the short-form drama sector.

Official data reveals that the company produced numerous high-quality short dramas during this period, with the proportion of breakout hits achieving over fifty million in popularity being three times higher than the market average.

In terms of genre strategy, the company achieved balanced development across both male and female audience segments.

In the male-oriented category, the series "The Invisible Bodyguard" consistently led in terms of online popularity and viewership data, achieving a platform popularity score exceeding 100 million and surpassing 5 billion total views across all networks. This made it the first male-oriented short drama in the industry to achieve both these milestones.

In the female-oriented category, China Literature focused on adapting existing intellectual properties and incubating original IPs. The original IP series "Sweet Wife" has generated cumulative profits exceeding 50 million yuan, establishing a new commercial benchmark for original short drama IPs in the industry.

Analyst reports predict the short-form drama industry will continue to evolve towards higher quality and AI-driven industrialization.

Changjiang Securities analysts noted that the accelerating integration of AI into content production will continue to enhance China Literature's efficiency in mass-producing premium content and support its further growth.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10